Abstract
Pandemic preparedness and response have become central to global health and are driving deep changes in management and resource allocation. Understanding COVID‐19's burden relative to other diseases and the impact of response interventions is therefore crucial for effective policy. The Global Burden of Disease (GBD) project has estimated 12.7 million COVID‐19 deaths within an excess mortality of 15.9 million for 2020–21, figures significantly higher than other sources. Given GBD's traditional importance for policymaking, we assessed the approach used and its likelihood of producing valid estimates. In doing so, analysis revealed that the GBD model assumes questionable higher‐than‐reported COVID‐19 mortality in populations with low vaccine uptake or low compliance with non‐pharmaceutical interventions (NPIs). GBD cites limited evidence for NPI effectiveness, counts response harms as excess mortality, and applies vaccine efficacies higher than many published reports, risking bias by inflating COVID‐19 mortality. To inform current policy changes in global policy, including proportionate and effective pandemic policy, it is critical to have a reliable understanding of the outcomes of the COVID‐19 event. The GBD's approach raises questions about the reliability of its mortality estimates and the public health response, suggesting a need for a better evidence base to inform future global health reform.

This publication has 29 references indexed in Scilit: